Resources

More active type 1 diabetes patients are at a greater risk for hypoglycemia and therefore may consume an increased amount of carbohydrates….

Awareness of prediabetes is low, less than 14% of people in the U.S. are aware of the condition….

Intradermal insulin injection via a microneedle provided less pain and increased kinetics….

Reduced calories before and after surgery improves diabetes in type 2 patients but not the actual surgery….

Diabetic patients on antidepressants who don’t understand basic health information are not as likely to continue taking medications….

With this week’s Homerun Slides, we begin a four-part series on managing hyperglycemia. This first set covers topics including Postprandial Hyperglycemia and Coronary Artery Disease, the Impact of Glycemic Variability, Glucose and A1C on Major Adverse Cardiac Events (MACE) After Acute MI, and how Increased PPG (Lower 1,5-AG) Correlates with …

Richard S. Beaser, MD Michael Johnstone, MD The week’s excerpt answers the following questions:  What is the relationship between triglyceride levels and the degree of insulin resistance? Which lipid abnormalities are markers of coronary artery disease (CAD)? What are the current goals for lipids for diabetic patients? Can improved glucose …

Andre McMahon, PharmD Candidate, University of Florida College of Pharmacy Dave Joffe, Editor-in-chief, Diabetes In Control The metabolic syndrome is associated with many risk factors for type 2 diabetes mellitus and cardiovascular complications which include: central obesity, elevated fasting glucose, elevated triglycerides, decreased high-density lipoprotein (HDL) cholesterol, and hypertension. When a …

CardeaScreen  A new portable highly accurate screening device helps to screen for heart problems in young athletes. Young athletes can be at risk of sudden cardiac arrest because of unrecognized congenital heart defects, but now a handheld device may help identify those at risk. The handheld CardeaScreen wirelessly connects to …

Johnson & Johnson’s SGLT2 canagliflozin (Invokana) has just received FDA approval, while Boehringer Ingelheim and Eli Lilly submit their SGLT2 inhibitor (empagliflozin) to the FDA…. U.S. health regulators have approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. …